Chih-Wei Ko
Overview
Explore the profile of Chih-Wei Ko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tso P, Vurma M, Ko C, Lee D, DeMichele S
Am J Physiol Gastrointest Liver Physiol
. 2018 Feb;
315(1):G95-G103.
PMID: 29470144
Breast milk lutein is better absorbed by infants than lutein delivered in infant formula. Therefore, we wanted to better understand the possible absorption differences of lutein in breast milk vs....
12.
Ko C, Counihan D, Wu J, Hatzoglou M, Puchowicz M, Croniger C
J Biol Chem
. 2018 Jan;
293(9):3399-3409.
PMID: 29317502
Phosphoenolpyruvate carboxykinase (Pck1) is a metabolic enzyme that is integral to the gluconeogenic and glyceroneogenic pathways. However, Pck1's role in macrophage metabolism and function is unknown. Using stable isotopomer MS...
13.
Packard A, Zhang J, Myers B, Ko C, Wang F, Tso P, et al.
Psychoneuroendocrinology
. 2017 Sep;
86:34-44.
PMID: 28910603
There is a critical gap in our knowledge of the mechanisms that govern interactions between daily life experiences (e.g., stress) and metabolic diseases, despite evidence that stress can have profound...
14.
Charrier A, Wang L, Stephenson E, Ghanta S, Ko C, Croniger C, et al.
Am J Physiol Endocrinol Metab
. 2016 Sep;
311(5):E869-E880.
PMID: 27624101
The peroxisome proliferator-activated receptor (PPAR) family of nuclear receptors is central to the pathophysiology and treatment of metabolic disease through the receptors' ability to regulate the expression of genes involved...
15.
DeSantis D, Ko C, Wang L, Lee P, Croniger C
Mediators Inflamm
. 2015 Dec;
2015:909827.
PMID: 26635450
TThe molecular mechanisms responsible for the development of hepatic fibrosis are not fully understood. The Nlrc4 inflammasome detects cytosolic presence of bacterial components, activating inflammatory cytokines to facilitate clearance of...
16.
DeSantis D, Ko C, Liu Y, Liu X, Hise A, Nunez G, et al.
Mediators Inflamm
. 2014 Jan;
2013:751374.
PMID: 24453428
Alcoholic liver disease (ALD) is characterized by increased hepatic lipid accumulation (steatosis) and inflammation with increased expression of proinflammatory cytokines. Two of these cytokines, interleukin-1 β (IL-1 β ) and...
17.
DeSantis D, Lee P, Doerner S, Ko C, Kawasoe J, Hill-Baskin A, et al.
Alcohol Clin Exp Res
. 2013 Jun;
37(10):1668-79.
PMID: 23763294
Background: Because the histological and biochemical progression of liver disease is similar in alcoholic steatohepatitis (ASH) and nonalcoholic steatohepatitis (NASH), we hypothesized that the genetic susceptibility to these liver diseases...
18.
Lin Y, Cho C, Ko C, Pulte A, Wu Y
J Org Chem
. 2012 Oct;
77(22):9979-88.
PMID: 23078637
A range of phenanthrene derivatives were efficiently synthesized by the palladium-catalyzed annulation of 2,2'-diiodobiphenyls with alkynes. The scope, limitations and regioselectivity of the reaction were investigated. The described method was...